Abstract
Objective Infliximab, a tumour necrosis factor-alpha (TNF alpha) antagonist, has advanced the management of ulcerative colitis. Although efficacious, ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
